Filing Details

Accession Number:
0001062993-15-001860
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-04-10 09:58:37
Reporting Period:
2015-04-07
Filing Date:
2015-04-10
Accepted Time:
2015-04-10 09:58:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1098880 Intelgenx Technologies Corp. IGXT Pharmaceutical Preparations (2834) 870638336
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1381868 Ingrid Zerbe 714 Main Road
Hudson A8 J0P 1H0
Corporate Secretary No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares ($0.0001 Par Value) Disposition 2015-04-07 20,000 $0.64 528,135 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Shares ($0.0001 Par Value) 5,158,221 Indirect See footnote
Footnotes
  1. In connection with the acquisition of IntelGenx in 2006, Ingrid Zerbe became our Corporate Secretary and Director of Finance and Administration and acquired 4,709,643.5 exchangeable Shares of our Canadian holding corporation 6544631Canada Inc., a Canadian special purpose corporation which wholly owns IntelGenx Corp. (the "Exchangeable Shares"). In June of 2009 Ms. Zerbe acquired 1,021,713 Exchangeable Shares from Joel Cohen in a private transaction. The 5,731,356.5 Exchangeable Shares are exchangeable, on a one for one basis, into shares of common stock of IntelGenx Technologies Corp. at Ms. Zerbe's discretion. As of today 573,135 exchangeable shares have been exchanged into common stock of IntelGenx Technologies Corp. Prior to exchanging the remaining Exchangeable Shares, Ms. Zerbe has the right to vote 5,158,221.5 shares of common stock which are currently held in trust on behalf of Ms. Zerbe. The common shares have not been registered for resale at this time.